Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A
Table 2
Local and systemic solicited adverse events (AEs) Day 0 through Day 7.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Local and systemic solicited adverse events (AEs) Day 0 through Day 7.